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Long-Term Plasticity of
Endocannabinoid Signaling Induced
by Developmental Febrile Seizures
ing at GABAergic synapses. Endocannabinoid-medi-
ated retrograde signaling, in particular, has been shown
to potently regulate transmitter release (Ha´jos et al.,
2000; Hoffman and Lupica, 2000; Wilson and Nicoll,
2001; Wilson et al., 2001; Kreitzer and Regehr, 2001;
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This signaling cascade is triggered by a transient depo-Hungary
larization of the postsynaptic neuron and results in the
endocannabinoid-mediated transient depression of
neurotransmitter release, a process termed depolariza-Summary
tion-induced suppression of inhibition (DSI, in the case
of GABAergic synapses) (Pitler and Alger, 1992) or depo-Febrile (fever-induced) seizures are the most common
larization-induced suppression of excitation (DSE, forform of childhood seizures, affecting 3%–5% of infants
glutamatergic synapses) (Ohno-Shosaku et al., 2002).and young children. Here we show that the activity-
Here we show that a single episode of hyperthermia-dependent, retrograde inhibition of GABA release by
induced prolonged seizures at postnatal day 10 (P10)endogenous cannabinoids is persistently enhanced in
leads to a novel form of long-term plasticity involvingthe rat hippocampus following a single episode of ex-
the enhancement of endocannabinoid-mediated sup-perimental prolonged febrile seizures during early
pression of GABA (but not glutamate) release, due to apostnatal development. The potentiation of endocan-
persistent upregulation of CB1 receptors selectively onnabinoid signaling results from an increase in the num-
cholecystokinin (CCK)-containing, perisomatic inhibi-ber of presynaptic cannabinoid type 1 receptors asso-
tory terminals synapsing on principal cells in the hippo-ciated with cholecystokinin-containing perisomatic
campus. To our knowledge, these findings constituteinhibitory inputs, without an effect on the endocannab-
the first evidence that the endocannabinoid system caninoid-mediated inhibition of glutamate release. These
be persistently modified in cortical networks.results demonstrate a selective, long-term increase
in the gain of endocannabinoid-mediated retrograde
Resultssignaling at GABAergic synapses in a model of a hu-
man neurological disease.
Long-Term Enhancement of Depolarization-Induced
Suppression of InhibitionIntroduction
Depolarization of CA1 pyramidal cells from control animals
for 500 ms resulted in a transient depression of the sponta-
A central question in understanding the neurobiological
neous, GABAA receptor-mediated, inhibitory postsynapticconsequences of seizures that take place during brain
currents (sIPSCs), a phenomenon known as DSI (Pitler
development concerns the precise nature of the long- and Alger, 1992) (Figure 1A, control; recordings were in
term alterations in GABAergic synaptic transmission. the presence of the glutamate receptor antagonists 10
Systematic prospective studies carried out in a novel
M APV and 5 M CNQX and 5 M of the cholinergic
experimental model system of prolonged (lasting more muscarinic agonist carbachol to boost sIPSC fre-
than 15 min) febrile seizures in the developing rat brain quency). Compared to controls, DSI was significantly
revealed a persistent, presynaptic, protein kinase-A- increased both in magnitude and duration in age-
dependent increase in the perisomatic GABAergic trans- matched littermates that had hyperthermia-induced ex-
mission in CA1 pyramidal cells (Chen et al., 1999). Fur- perimental febrile seizures (HT) 1 week before the re-
thermore, experimental febrile seizures also resulted in cording session (Figures 1A and 1B; DSI amplitude in
a long-term increase in the hyperpolarization-activated, control: 20.2%  2.7%, expressed as percent decrease
depolarizing conductance Ih in the postsynaptic mem- in sIPSC charge transfer following the depolarizing
brane that limited the efficacy of the potentiated periso- pulse, with respect to the prepulse control period; DSI
matic GABAergic inputs in a frequency-dependent man- in HT: 33%  3.7%; decay time constant of DSI in con-
ner (Chen et al., 2001). In addition to distinct pre- and trol: 2.2 s; in HT: 12.5 s; control: n  11 cells from three
postsynaptic mechanisms of plasticity, seizures in de- animals; HT: n  10 cells from four animals). To our
velopment may also persistently alter retrograde signal- knowledge, this is the first demonstration that DSI can
be altered in a persistent manner (i.e., lasting at least 1
week; for longer time points, see below).*Correspondence: isoltesz@uci.edu
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Figure 1. Long-Term Enhancement of Depolarization-Induced Suppression of Inhibition after Experimental Febrile Seizures
(A) Current traces from CA1 pyramidal cells from a littermate control (Control) and from an animal that experienced hyperthermia-induced
experimental febrile seizures (HT) 1 week before the recording session at postnatal day 10 (the recordings were carried out in the presence
of ionotropic glutamate receptor antagonists and carbachol, see text). The spontaneous IPSCs appeared depressed shortly after a depolarizing
voltage step (500 ms to 0 mV, indicated by the square pulse above the traces), representing DSI. Note that the depression was more pronounced
and longer lasting in the cell from the HT animal.
(B) Combined data from recordings similar to those in (A). The DSI decay was adequately described with a single exponential fit (control,
empty circles; HT, filled circles, as in the rest of the figure).
(C) Enhanced DSI was present also when a 5 s long depolarization was used. (Inset) DSI was abolished both in control and HT animals with
the CB1 receptor antagonist 1 M SR.
(D) Potentiation of DSI was also present when a short (100 ms) depolarizing pulse was used in the absence of carbachol.
(E) Potentiation of DSI in HT animals was long lasting (5 weeks after seizure induction; depolarizing pulse duration: 500 ms).
(F) Dentate granule cells, which do not normally show DSI in control animals, exhibited significant DSI after the seizures (HT) (depolarizing
pulse duration: 5 s). (Inset) SR abolished DSI in dentate granule cells from HT animals.
The frequency of both the action potential-indepen- charge transfer in the control group: 99.0%  12%; DSI
in these two subsets of cells: control, 20.4%  3.4%,dent miniature IPSCs (mIPSCs, recorded in the presence
of the Na channel blocker tetrodotoxin) and the action n  8; HT, 32.4%  4.3%, n  8).
The potentiation of DSI could also be observed whenpotential-dependent sIPSCs (recorded in the absence
of tetrodotoxin) was reported to be enhanced in a long- long depolarizing current pulses (5 s, instead of the
500 ms used in the previous experiments) were used toterm manner in CA1 cells from HT animals (Chen et al.,
1999, 2001; Figure 1A). However, the potentiated DSI evoke DSI (Figure 1C), indicating that the increase in
DSI was present with a wide range of depolarizing stimuliwas not simply a consequence of the presence of
higher-frequency sIPSCs, since DSI in HT animals was (in fact, the potentiation was present even with a 100
ms pulse, see below). DSI was mediated by cannabinoidsignificantly larger even when the difference in sIPSC
activity was eliminated by comparing a subset of control receptors in both controls and postseizure animals,
since the CB1 cannabinoid receptor antagonistcells with the most intense sIPSC activity with a subset
of cells from HT animals with the least intense sIPSC SR141716A (SR; 1 M) (Rinaldi-Carmona et al., 1994)
abolished DSI in both groups (Figure 1C, inset; DSI inactivity (baseline sIPSC charge transfer in this subset
of cells from HT animals, expressed as a percent of the SR in control: 0.2%  2.3%, n  4; HT: 3.5%  2.6%,
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n  5; additional experiments showed that 0.005% in the presence of the mGluR antagonist LY341495 (200
M, a concentration which blocks all mGluRs; FitzjohnDMSO, used to dissolve SR, did not change DSI in cells
et al., 1998) did not abolish the difference between DSIfrom either control or HT animals. DSI in DMSO in control
measured from control and HT animals (DSI in control:cells: 17.0%  4.0%, n  3; compared to DSI without
10.2%  3.7%, n  7; in HT: 24%  4.8%, n  8; FigureDMSO: 15.6% 2.2%, n 6; DSI in DMSO in cells from
2A, inset; note that the mGluR antagonist decreasedHT animals: 35.2% 7.5%, n  4, compared to without
DSI in both control and HT groups). Muscarinic receptorDMSO: 34.4%  4.6%, n  6).
activation also enhances endocannabinoid release andFurthermore, DSI was also larger in cells from HT
thus potentiates DSI (Kim et al., 2002). However, tonicanimals when the experiments were carried out in the
increase in acetylcholine levels in the extracellular spaceabsence of carbachol and a short depolarizing pulse
could not underlie the observed potentiation of DSI,(100 ms) was used to evoke DSI (Figure 1D; under these
since DSI in cells from HT animals remained significantlyconditions, DSI was small and not significant in controls:
larger compared to controls when slices from both8.2% 3.6%, n 7; but DSI was present in HT: 24.5%
groups were incubated (45 min) in the presence of the3.2%, n  9). The potentiation of DSI was persistent,
muscarinic receptor antagonist atropine (1 M) (DSI insince it was still present even 5 weeks after seizure
controls: 15.3%  4.9%, n  6; DSI in HT: 33.9% induction (Figure 1E; DSI in control: 15.3%  4.8%, n
5.0%, n  6; Figure 2A, inset).10; in HT: 31.9% 2.5%, n  10; note that the enhance-
In the experiments described above, the ligands forment of DSI was unchanged from 1 week to 5 weeks
the CB1 receptors were presumably released from thefollowing the seizures, compare Figures 1B and 1E).
recorded cells. Therefore, in the next series of experi-In contrast to CA1 pyramidal cells, dentate granule
ments we tested the effects of an exogenously appliedcells have not been shown to exhibit DSI. Although den-
cannabinoid agonist. WIN55212-2 (WIN; 5 M) causedtate granule cells in control animals did not show DSI
a larger decrease in the amplitude of eIPSCs in cells(DSI in control:0.1 3.5, n 10), significant DSI could
from HT animals compared to controls and abolishedbe observed in these cells 1 week after seizure induction
the difference in eIPSCs between the two groups (Figure(Figure 1F; DSI in HT: 18.5%  3.7%, n  9; pulse
2B; in the upper panel, eIPSCs were examined in theduration in both the control and HT groups: 5 s), indicat-
same cells before and after switching the perfusate toing that experimental febrile seizures can induce this
a solution containing WIN, control: n  10, HT: n  10;form of activity-dependent plasticity of the inhibitory
additional experiments showed that 0.1% DMSO, usedsystem even in cell types that do not typically exhibit
to dissolve WIN, had no significant effect on the ampli-DSI. The DSI observed in granule cells from HT animals
tude of the eIPSCs: change in eIPSC amplitude aftercould be fully blocked by the CB1 receptor antagonist
switching the perfusate to a medium containing DMSO,SR (Figure 1F, inset; DSI granule cells from HT animals
with respect to the pre-DMSO baseline: 2.7%  6.7%,in SR: 0.8%  3.3%, n  9).
n 4 HT cells; in the lower panel of Figure 2B, the slicesIn the experiments described above, spontaneous
were incubated in control medium or in WIN for 40–60IPSCs were used to examine the long-term modifica-
min; control cells without WIN: n  6; control with WIN:tions in DSI after the seizures. As shown in Figure 2A, DSI
n  6; HT without WIN: n  7; HT with WIN: n  7). WINwas also significantly larger when IPSCs were evoked
(5 M) had no effect on the eIPSCs in cells from eitherby electrical stimulation (eIPSCs were elicited by an
control or HT animals in the presence of the CB1 antago-electrode placed near the somatic layer at a constant
nist SR (1 M; Figure 2C; control cells: n  6; HT: n distance from the recording electrode, as described in
6). Furthermore, WIN had a larger effect on eIPSCs in theChen et al., 1999; DSI of eIPSCs in controls: 24.2% 
postseizure animals even 11 weeks after the induction of5.4%, n  8; in HT: 40.1%  5.5%, n  10; all experi-
the seizures (Figure 2D; the slices were incubated in 5ments involving eIPSCs were carried out in the absence
M WIN for 30–60 min; control without WIN: n  10;
of carbachol). Therefore, the potentiation of DSI was
control with WIN: n  8; HT without WIN: n  9; HT with
present with both spontaneously occurring and stimula-
WIN: n  5). These findings showed that 5 M WIN had
tion-evoked GABAergic synaptic events. Taken to- a significantly larger effect on eIPSCs after the seizures,
gether, these data, obtained with either 100 ms, 500 ms, in agreement with the results obtained with DSI.
or 5 s depolarizing pulses, in the presence or absence CB1 receptor activation with WIN in the hippocampus
of carbachol, with sIPSCs or eIPSCs, demonstrate that in normal extracellular medium (i.e., in the absence of
DSI is significantly potentiated in a long-term manner elevated levels of extracellular K and Ca2) typically
in principal cells of the hippocampus following a single does not alter the frequency or amplitude of mIPSCs
episode of experimental febrile seizures. (Hoffman and Lupica, 2000). The mIPSC frequency was
previously shown to be persistently enhanced after ex-
Mechanisms of the Persistent Increase perimental complex febrile seizures, without a change
in Endocannabinoid Signaling in mIPSC amplitude (Chen et al., 1999). The elevated
at GABAergic Synapses frequency of the mIPSCs after the seizure induction re-
Since recent reports indicate that metabotropic gluta- mained insensitive to CB1 receptor activation (note that
mate receptor activation increases DSI (Varma et al., the elevated mIPSC frequency was also insensitive to
2001), we tested the possibility that the potentiation of blockade of voltage-gated Ca2 channels; Chen et al.,
DSI took place because of increased tonic metabotropic 1999). Specifically, the frequency of mIPSCs in cells
glutamate receptor (mGluR) activation after the seizures from HT animals remained increased in the presence of
(e.g., resulting from enhanced extracellular glutamate WIN (5 M), since the agonist had no significant effect
on the frequency or the amplitude of the mIPSCs inconcentration). Prolonged (30 min) incubation of slices
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Figure 2. Persistent Increase in DSI of Evoked IPSCs, and Effects of Exogenously Applied Cannabinoid Agonist
(A) The enhancement of DSI (1 week after seizure induction) was present not only with spontaneous IPSCs in carbachol (Figure 1) but also
with evoked IPSCs without carbachol (depolarizing pulse: 5 s). (Inset) DSI remained enhanced after the seizures (HT) in the presence of the
metabotropic glutamate receptor antagonist LY341495 or the muscarinic receptor blocker atropine.
(B) The cannabinoid agonist WIN (5 M) depressed the eIPSCs to a greater extent in cells from HT animals, both when the agonist was
washed in following a period of pre-drug recording (upper panels) and when the slices were incubated either with or without the agonist
(bottom panel).
(C) In the presence of the CB1 antagonist SR (1 M), switching the perfusate to WIN (5 M) had no effect on the eIPSCs in cells from either
control or HT animals.
(D) The CB1 agonist had a larger effect on eIPSCs, even 11 weeks after the seizure episode.
(E and F) The CB1 agonist had no effect on the frequency (E) or amplitude (F) of miniature IPSCs (note that the frequency of mIPSCs is
enhanced in HT animals, Chen et al., 1999).
either the control or the postseizure group (Figures 2E zures also indicates that this putative presynaptic mech-
anism underlying the enhanced endocannabinoid-medi-and 2F; control without WIN: n  15; control with WIN:
n  14; HT without WIN: n  15; HT with WIN: n  13; ated retrograde signaling following the seizures is
specific to action potential-dependent GABA release.the slices were incubated in 5 M WIN for 25–50 min;
1 week after seizures). In order to determine the nature of the presynaptic
mechanisms that may be involved in the long-term plas-The results obtained with the exogenous application
of the CB1 receptor agonist WIN indicate that the long- ticity of DSI, the effect of the CB1 receptor antagonist
SR (1 M) was tested on eIPSCs. In agreement withlasting potentiation of DSI in CA1 pyramidal cells after
hyperthermia-induced seizures is likely to involve a pre- previous reports, SR had no effect on the eIPSCs in
controls (Hoffman and Lupica, 2000; Wilson and Nicoll,synaptic locus, since an exclusively postsynaptic mech-
anism alone, e.g., enhanced release of endocannabinoid 2001). However, SR caused a significant increase in the
eIPSCs after the seizures (Figure 3A; for the results inligands in response to the same amount of depolariza-
tion, cannot explain the fact that exogenous application the lower panel, the slices were incubated either without
or with SR for30 min; control without SR: n 6; controlof WIN had a larger effect on the eIPSCs after the sei-
zures compared to controls. Moreover, the lack of sensi- with SR: n  7; HT without SR: n  7; HT with SR: n 
7; similar results were obtained when the perfusate wastivity of the mIPSCs to cannabinoid receptor activation
in cells from animals that had experimental febrile sei- switched to SR during recordings from the same cells,
Long-Term Plasticity of Cannabinoid Signaling
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Figure 3. Specificity of Seizure-Induced Alterations in Endocannabinoid Signaling
(A) The CB1 receptor antagonist SR (1 M) had no significant effect on eIPSCs in controls; however, it caused an increase in the peak
amplitude of the eIPSCs in cells from animals that experienced seizures 1 week before (HT).
(B) Time course of the SR effect on eIPSCs.
(C) HPLC experiments indicate that the concentrations of anandamide and 2-AG did not change in the hippocampus after the seizures.
(D) In spite of the marked changes in DSI, DSE was not altered by the seizures (depolarizing step: 10 s). (Inset) SR (1 M) abolished DSE in
both control and postseizure animals.
(E) In agreement with the lack of alteration in DSE, the CB1 agonist WIN (5 M) caused similar changes in the eEPSCs in cells from control
and HT animals.
(F and G) Enzyme activity assays showed lack of seizure-induced alterations in cannabinoid breakdown for either monoglycerol lipase (MGL,
in [E]) or for fatty acid amino hydrolase (FAAH, in [F]).
as shown in Figure 3A, upper panel; enhancement of endocannabinoid ligands. Although this mechanism
was unlikely, given both the more intense sIPSC activitythe eIPSC amplitude by SR in cells from HT animals:
35%17%, n10, with respect to the pre-SR baseline). and the potentiated eIPSCs in cells from HT animals,
experiments were carried out to measure the steady-The time course of the SR effect on eIPSCs, indicating
saturation of the SR-induced enhancement of the state levels of endocannabinoids in the hippocampi of
control and HT animals. High-performance liquid chro-eIPSCs in cells from HT animals, is shown in Figure
3B (SR effect measured 5–10 min after switching the matography/mass spectrometry (HPLC/MS) analyses
(Giuffrida et al., 2000; Dinh et al., 2002) revealed noperfusate to SR, expressed as percent of pre-SR base-
line, in control: 99.7%  3.2%, n  5; HT: 134.7%  significant change in the concentrations of either anan-
damide or 2-AG in the hippocampus of HT animals (Fig-4.7%, n  6; note that the data in Figure 3B are from a
different set of cells than in Figure 3A, since in the time ure 3C; anandamide, in pmol/g hippocampal tissue, con-
trols: 5.40  0.89, n  4; HT: 4.75  0.83, n  4; 2-AG,course experiments only a single stimulation intensity
was used in order to monitor the development of the in nmol/g hippocampal tissue, controls: 1.56 0.26, n
4; HT: 1.72 0.41, n 4; 1 week after seizure induction).SR action).
One possible explanation for the amplitude-enhanc- Although the HPLC/MS assay could not determine the
ligand concentration selectively in the extracellularing effect of the CB1 antagonist on the eIPSCs after
the seizures is that there is a tonic activation of CB1 space, these data indicated the lack of a large, sustained
change in the total levels of endocannabinoids in thereceptors due to increased steady-state levels of the
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postseizure tissue (additional evidence arguing against slower kinetics of the DSI decay after the seizures was
not due to an AM-404-blockable uptake system. Thesealterations in endocannabinoid release came from the
DSE experiments described below). results were in agreement with our endocannabinoid
measurements, indicating that the steady-state levels
of endocannabinoids remained unchanged. As reportedPotentiation of the Endocannabinoid-Mediated
before (Wilson and Nicoll, 2001), AM-404 also decreasedRetrograde Signaling System Is Specific
the amplitude of DSI (perhaps due to occlusion of DSIto Inhibitory Synapses
following the blockade of endocannabinoid uptake; Wil-It has been reported recently that activity-dependent
son and Nicoll, 2001), in both controls and postseizurerelease of endocannabinoids can depress transmitter
animals (decrease in DSI in AM-404 after 10–15 minrelease not only from GABAergic axons but also from
perfusion, with respect to the pre-AM-404 DSI: control,glutamatergic terminals (Ohno-Shosaku et al., 2002). Al-
37.9%  20.2%, n  5; HT, 49.4%  19.1%, n  5;though it is not yet clear whether a different endocan-
difference is not significant; data not shown), indicatingnabinoid acts on CB receptors on inhibitory versus excit-
that AM-404 reached the recorded cell, and therefore,atory terminals and/or whether a novel CB-like receptor
the lack of an effect of AM-404 on the DSI decay wasexists on GABAergic versus glutamatergic axons (Ha´jos
not due to a lack of penetration of the drug into theand Freund, 2002), DSE offers a possibility to examine
slice.whether the enhanced amplitude and prolonged decay
The larger amplitude and longer decay of DSI follow-of the suppression of transmitter release by endocan-
ing experimental complex febrile seizures could alsonabinoids after experimental complex febrile seizures
take place if the activity of the enzymes that inactivateis specific to inhibitory terminals. As shown in Figure
the endocannabinoids was reduced following the sei-3D, DSE was identical in CA1 cells from control and
zures. However, enzyme activity assays for monoacyl-postseizure animals (1 week after the seizures; DSE in
glycerol lipase (MGL) (Dinh et al., 2002) and fatty acidcontrols: 15.8%  4.2%, n  8; in HT: 14.2%  3.2%,
amide hydrolase (FAAH) (Desarnaud et al., 1995; Cravattn  8; DSE was evoked using a 10 s long pulse; Ohno-
et al., 1996) in the hippocampus did not reveal any signif-Shosaku et al., 2002), indicating that there is no overall
icant alteration between control and postseizure groupsincrease in the endocannabinoid-mediated retrograde
(Figures 3F and 3G; MGL activity, in pmol/min/mg pro-signaling system involving both the excitatory and inhib-
tein: control, 47.2  1.1, n  6; HT, 47.3  1.3; n  5;itory terminals. The selective enhancement of DSI but
FAAH: control, 1242.5  29.9, n  6; HT, 1244.7  35.2,not DSE is also consistent with the results described
n  5). Together, these results indicated that changesabove that indicate that the potentiation of DSI has a
in endocannabinoid-inactivating systems were unlikelypresynaptic locus and that it is not due to a postsynaptic
to underlie the persistent potentiation of DSI after sei-mechanism such as increased release of endocannabi-
zures.noids from the pyramidal cells. The DSE in cells from
both control (Ohno-Shosaku et al., 2002) and postsei-
zure animals could be abolished by the CB1 receptor Unchanged Site Specificity of Expression but Increased
antagonist SR (1 M) (Figure 3D, inset; DSE with SR: Numbers of CB1 Receptors following Experimental
control: 6.9%  5%, n  7; HT: 5.8%  5.3%, n  7; Febrile Seizures
the effect of SR on DSE was significant). In agreement The electrophysiological data on the enhanced effects
with the lack of alterations in DSE and in contrast to the of the exogenously applied cannabinoid agonist on
larger effect of 5 M WIN on eIPSCs from HT animals eIPSCs in cells from HT animals, together with a lack of
(Figure 2B), WIN (5 M) did not cause a differential significant alterations in endocannabinoid levels, were
change in eEPSCs in cells from control and postseizure consistent with a presynaptic locus for the observed
animals (1 week after seizures; Figure 3E; n  8 cells in long-term plasticity of DSI. Therefore, we tested the
all four groups). hypothesis that the expression levels of presynaptic
CB1 receptors changed following the seizures. Double-
labeling experiments showed that immunoreactivity forLack of Changes in the Endogenous
Cannabinoid-Inactivating Systems CB1 receptors was localized specifically to CCK-posi-
tive cells and axons (Figures 4A and 4B) but not toAlterations in the uptake of endogenously released can-
nabinoids may contribute to the changes in DSI after parvalbumin (PV)-positive processes (Figures 4C and
4D), both in controls (data not shown; Katona et al.,the seizures, particularly to the prolonged DSI decay in
HT animals. However, experiments with AM-404 (20M), 1999; Tsou et al., 1999) and after experimental complex
febrile seizures (Figures 4A–4D; number of CCK-labeledan inhibitor of the anandamide/2-AG transporter (Bel-
tramo et al., 1997), showed that blockade of endocan- axon-like processes double labeled for CB1 receptors:
control, 179/183, i.e., 97.7% of CCK-containing pro-nabinoid uptake did not prolong the decay of the DSI
in either the control (in agreement with previous reports, cesses were also positive for CB1 receptors, n  3
animals; HT, 159/165, 96.4%, n  3; number of PV-Wilson and Nicoll, 2001) or the HT groups (DSI decay
time constants: control, before AM-404, 5.9 s; after AM- labeled presumed axons double labeled for CB1 recep-
tors: control, 0/252, 0%, n  4; HT, 0/264, 0%, n  4).404, 4.5 s, n  6; HT, before AM-404, 12.5 s; after AM-
404, 11.1 s, n  6; the perfusate was switched from a These findings indicated that the high specificity of CB1
receptor expression in hippocampal interneurons (Ka-control solution to a medium containing AM-404 for
10–15 min; DSI was evoked using 5 s depolarizing tona et al., 1999; Tsou et al., 1999; Wilson et al., 2001)
was preserved after the experimental complex febrilepulses, in the presence of carbachol; 1 week postsei-
zure; data not shown). These findings indicated that the seizures. The characteristic layer-specific pattern of
Long-Term Plasticity of Cannabinoid Signaling
605
high: control: 1.0 0.08; HT: 0.771 0.1; neurofilament
low: conrol: 1.0  0.181; HT: 0.95  0.12; n  4 animals
in both groups). These Western blotting results show a
significant upregulation of CB1 receptors in the hippo-
campus after complex febrile seizures.
Potentiation of DSI of Cannabinoid-Sensitive
Single-Fiber Responses
What is the relationship between the increased DSI and
the enhanced CB1 receptor number? The increased DSI
in the experiments carried out on sIPSCs (Figure 1) or
multifiber eIPSCs (Figures 2A and 2B) could have origi-
nated simply from a relative potentiation of the GABA
responses originating from CB1 receptor-containing ax-
ons, without an involvement of the increased CB1 recep-
tor number. In order to examine this question, mimimal
stimulation-evoked, presumed unitary, single-fiber
IPSCs (meIPSCs; Figures 5A and 5B) were examined in
slices incubated in 250 nM -agatoxin TK, a P/Q-type
voltage-dependent Ca2 channel antagonist which has
been shown to block the GABA release from perisomatic
fibers that are not sensitive to cannabinoids (Wilson et
al., 2001). The meIPSCs recorded under these condi-
tions from CA1 cells from HT animals were larger com-
pared to controls (Figure 5C; control: 67.0  6 pA, n 
17; HT: 90.0 8 pA, n 24; rise time constants: control:
0.67 0.06 ms; HT: 0.69 0.07 ms). As shown in Figures
5D and 5E, DSI was significantly enhanced after the
seizures (DSI following a 1 s long depolarizing pulse inFigure 4. Increased Number of CB1 Receptors after Experimental
Febrile Seizures control: 45%  13%, n  8; in HT: 76%  6%, n 
16; note that all unitary responses tested under these(A–D) Similar to littermate control animals (data not shown; Katona
et al., 1999), CB1 receptors after the seizures (A–D) remained local- conditions exhibited DSI, in agreement with Wilson et
ized to CCK processes (A and B), whereas PV processes (arrows) al., 2001). In five cells in each group, the effect of WIN
remained CB1 negative (C and D). Note that the CB1 axon termi- was also tested on the meIPSCs. In each case, WIN (5
nals indicated by arrowheads in (B) surround the PV, CB1-negative
M) completely abolished the meIPSCs (Figures 5D andinterneuron indicated by the asterisk.
5E), indicating that the lack of a complete (100%) DSI(E–H) The characteristic layer-specific pattern of CB1 receptor stain-
following a 1 s depolarizing pulse was not due to theing was unchanged after the seizures, both in CA1 (E and F) and
dentate gyrus (G and H), but the staining intensity appeared stronger involvement of a cannabinoid-insensitive component
after the seizures (so, stratum oriens; pr, stratum pyramidale; sr, (note that there was no difference in the time course of
stratum radiatum; hl, hilus; gl, granule cell layer; ml, molecular layer). the WIN effect on the meIPSCs from cells in control
(I and J) Western blots (I) (performed on hippocampal tissue) and
and HT animals; Figure 5F). The enhanced meIPSCstheir quantitative analysis (J) show the over 2-fold increase in CB1
recorded from slices incubated in -agatoxin TK sug-receptors after the seizures (HT) compared to littermate controls
gest that the potentiation of DSI of the sIPSCs and the(CON), without changes in control proteins (NF, neurofilament; NF
(high), 200 kDa and 160 kDa; NF (low), 68 kDa in [G]). The right-hand multifiber eIPSCs was, at least in part, due to a relative
panel in (I) illustrates the lack of detectable proteins with antibody increase of the GABA responses originating from the
preincubated with fusion protein and in the no primary antibody CB1-containing axons. These results are consistent with
control blots. Each lane in (I) represents a different animal (note the
the observation that WIN abolished the difference be-consistently enhanced quantity of CB1 receptors in each of the HT
tween the eIPCSs from control and HT animals (Figureanimals in the blots in [I]).
2B). However, the fact that DSI was enhanced in cellsScale bars, 10 m (A and B); 20 m (C and D); 50 m (E–H).
from HT animals even when the DSI-susceptible unitary
responses were examined in isolation in the minimal
stimulation experiments indicates that the increase inCB1 receptor staining (Katona et al., 1999) was un-
the number of CB1 receptors enhances the sensitivity ofchanged after the seizures, both in the CA1 (Figures 4E
the axon terminals to endocannabinoids and, therefore,and 4F) and the dentate gyrus (Figures 4G and 4H), but
contributes to the observed increased in DSI of sIPSCsthe staining intensity qualitatively appeared stronger in
and eIPSCs.animals that experienced seizures. Quantitative Western
blot analyses demonstrated a significant increase in
CB1 receptor protein in hippocampi from animals that Lack of Sprouting of CB1-Containing Axons
Next, we examined whether the increased number ofexperienced seizures, compared to controls (Figures 4I
and 4J), without alterations in the amount of control CB1 receptors and the enhancement of the DSI-suscep-
tible responses (Figure 5C) were due to an increase inproteins (all values represent fold changes, normalized
to mean control values: CB1 receptor: control: 1.0  the number of synapses made by CB1-containing axons
on CA1 pyramidal cell somata. Quantitative electron mi-0.04; HT: 2.28  0.1; control proteins: neurofilament
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Figure 5. Potentiated DSI of Single-Fiber IPSCs
(A and B) Minimal stimulation-evoked IPSCs (meIPSCs) from a CA1 cell from a control (A) and an HT (B) animal exhibit a sharp, stepwise
increase in peak amplitude with increasing stimulation intensity, indicating the successful isolation of a single fiber.
(C) Summary data show that the meIPSCs were larger after the seizures (1 week following seizure induction; all recordings were in slices
incubated in -agatoxin TK).
(D) The DSI of meIPSCs was significantly enhanced after the seizures (meIPSCs are shown before and after the 1 s depolarizing pulse). WIN
(5 M) invariably abolished the meIPSCs, indicating that the lack of a complete (100%) DSI following a 1 s depolarizing pulse was not due
to the involvement of a cannabinoid-insensitive component.
(E) Summary data of the DSI of the meIPSCs.
(F) There was no difference in the time course of the WIN effect on meIPSCs between the two groups.
croscopy, based on the dissector sampling method that These electron microscopic results were indepen-
dently corroborated using a different approach based onis not sensitive to changes in the size of the examined
objects (West, 1999; see legend to Figures 6D and 6E preembedding immunogold staining of CB1-containing
processes (see Experimental Procedures and Figuresand Experimental Procedures), showed no significant
seizure-induced increases in the number of CB1-immu- 6F–6I; the major advantage of the technique is that tens
of thousands of profiles can be sampled, which is notnoreactive synapses on pyramidal cell bodies (Figures
6A–6E and 6J; synapse density: control, 10.2  0.9 per practical with electron microscopy). Again, there was
no evidence of sprouting of the CB1-positive axons in103 m3, n  145 synapses from n  3 animals; HT,
12.2  0.7 per 103 m3, n  160 synapses from n  3 either the pyramidal cell layer (Figure 6L; control: 34.3
1.0 profiles per 103 m2, n 10,310; from n 3 animals;animals). Similarly to the identified CB1-positive syn-
apses, there was also no significant increase in the num- HT: 31.9  0.9 profiles per 103 m2, n  11,615; from
n  3 animals) or in the stratum radiatum (Figure 6M;ber of transected CB1-immunostained axonal profiles
(including synaptic terminals, as well as terminals that control: 54.3  1.7 profiles per 103 m2, n  12,706; HT:
50.2  1.5 profiles per 103 m2, n  13,005). Note thatin the examined section did not make synapses, and
interterminal axon segments; see arrows in Figures 6A an internal control for the validity of the light microscopic
sampling based on the preembedding immunogoldand 6B) per unit area within the CA1 pyramidal cell layer
(Figure 6K; control: 30.0  2.2 profiles per 103 m2, n  technique was the fact that the profile density obtained
with the electron microscopic sampling was similar to1020; HT: 33.7  2.7 profiles per 103 m2, n  1042).
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the data from the preembedding immunogold method
(compare the data in Figure 6K with Figure 6L). Taken
together, these data showed that the mechanism under-
lying the enhanced meIPSCs peak amplitude and the
increase in CB1 receptor numbers per unit weight of
hippocampal tissue (Figures 4I and 4J) was not sprout-
ing of CB1/CCK-positive axons. Since there was no sig-
nificant sprouting, the increase in the CB1 receptor den-
sity detected using Western blots most likely reflected
an increase in the number of CB1-positive receptors
on the axon terminals of CCK-positive interneurons, in
agreement with the electrophysiological data.
Discussion
Experimental prolonged, complex febrile seizures result
in a long-term, PKA-dependent, presynaptic potentia-
tion of perisomatic, GABAA receptor-mediated IPSCs in
CA1 pyramidal cells (Chen et al., 1999), and they also
persistently modify intrinsic membrane currents such
as Ih in the postsynaptic membrane (Chen et al., 2001).
Here we demonstrate that febrile seizures lead to long-
term alterations in the endocannabinoid-mediated, ret-
rograde signaling at perisomatic GABAergic synapses.
The data in this paper support the general conclusion of
our previous studies that a single episode of prolonged
febrile seizures (which are the type of febrile seizures
that are most consistently associated with subsequent
temporal lobe epilepsy; Shinnar, 1998) in the hyperther-
mia model in rats causes long-lasting changes in neu-
ronal excitability in the limbic system (for reviews on the
effects of early life seizures, see Holmes and Ben-Ari,
1998; Walker and Kullmann, 1999).Figure 6. Lack of Sprouting of CB1-Positive Axons after the Sei-
To our knowledge, the data show for the first timezures
that the activity-dependent, CB1 receptor-mediated de-(A and B) Low-power electron micrographs of the stratum pyrami-
pression of GABA release can undergo persistent alter-dale are shown from control (A) and HT animals (B). Transected,
immunolabeled profiles (including terminals and interterminal axon ations. Long-term plasticity in the gain of retrograde,
segments) are indicated by arrows. endocannabinoid-mediated signaling could result from
(C) The framed area in (B) is shown at a higher magnification. postsynaptic (e.g., changes in endocannabinoid re-
(D and E) Illustration of the dissector method. The framed area in
lease) or presynaptic factors (Varma et al., 2002), and/or(C) at even higher magnification in (D) reveals the presence of two
modifications in endocannabinoid-inactivating systems.perisomatic CB1-positive synapses. In (E), the image of the same
Out of these potential regulatory sites, our data pointarea as in (D) three sections (210 nm) away shows the absence of
synapses. With the dissector method, only those synapses were to an increase in CB1 receptors on CCK-positive
counted which were present in the first but not in the fourth section. interneuronal axon terminals, many of which make peri-
Thus, both of the synapses in (D) were counted, since they were somatic synapses on hippocampal principal cells. The
not present in (E).
postseizure increase in CB1 receptor expression was(F–I) Light microscopic images of the preembedding CB1 receptor
indicated by the Western blot experiments and was con-immunogold staining from control (F) and HT (H) animals show the
sistent with the enhanced DSI amplitude. The seizure-immunopositive axons in stratum pyramidale. The background of
the grayscale images (F and H) was subtracted using high-pass induced alterations in CB1 signaling were strong enough
filtering, resulting in corresponding binary images ([G] for [F] and [I] to convert a population of principal cells, the dentate
for [H]) where the number of the immunostained axonal profiles granule cells that do not normally express DSI, to exhibit
could be counted.
robust DSI, indicating an enhanced role for endocannab-(J–M) Quantitative data from the electron microscopic measurement
inoids in regulating neuronal excitability levels within theof the density of CB1 synapses (J) and axonal profiles ([K]; see
postseizure limbic networks.arrows in [A] and [B]) in the pyramidal cell layer (PCL). The CB1
axonal profile density from the immunogold experiments was deter- Since sIPSCs and eIPSCs constitute mixed responses
mined for both the pyramidal cell layer (L) and the stratum radiatum that include both cannabinoid-sensitive and -insensitive
([M]; SR, stratum radiatum). Note that the profile densities obtained components, a selective increase in the amplitude of
with electron microscopy (K) and with the immunogold technique
the cannabinoid-sensitive IPSCs alone could also en-(L) were similar.
hance the DSI of sIPSCs and eIPSCs, irrespective ofScale bars, 10 m (A and B); 5 m (C); 1 m (D and E); 20 m (F).
alterations in CB1 receptor numbers. Indeed, WIN in
the experiments in Figure 2B abolished the difference
between the eIPSCs in cells from control and HT ani-
mals, indicating that a selective potentiation of the can-
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nabinoid-sensitive synaptic inputs took place after the only on those interneurons which normally express
seizure induction. Consistent with these data, the these receptors, i.e., on the CCK-positive basket cells,
meIPSC amplitude in -agatoxin TK was significantly because no CB1 receptor expression could be observed
increased (Figure 5C). While a selective potentiation of on parvalbumin-positive interneurons either in controls
the IPSCs evoked by GABA from CB1 receptor-con- or in HT animals (CCK- or parvalbumin-containing
taining fibers may contribute to the increased DSI of interneurons together make up the total basket cell pop-
sIPSCs and eIPSCs, it cannot explain the fact that DSI ulation, Freund and Buzsa´ki, 1996; experimental febrile
was enhanced even in the case of the single-fiber seizures do not lead to hippocampal cell loss, Toth et
meIPSCs in -agatoxin TK (Figure 5E), i.e., under condi- al., 1998). The seizure-induced enhancement in canna-
tions when only the DSI-susceptible inputs were stud- binoid signaling was selective also in terms of affecting
ied. Therefore, the potentiation of DSI of the meIPSCs GABAergic but not glutamatergic terminals, since only
in -agatoxin TK indicates that the increased number DSI, but not DSE, showed significant alterations follow-
of CB1 receptors constitutes a major mechanism under- ing the seizures.
lying the potentiation of the endocannabinoid-mediated, GABAergic transmission is involved in a diverse array
activity-dependent inhibition of GABA release after the of functional roles (McBain and Fisahn, 2001), and the
seizures. data in this paper show that, in addition to pre- and
The long-term modification in the endocannabinoid postsynaptic plasticity mechanisms (Nusser et al., 1998;
signaling was not restricted to potentiation of peak DSI, Brooks-Kayal et al., 1998; Chen et al., 1999, 2001; Chev-
since it also included the ability of the CB1 antagonist aleyre and Castillo, 2003), the endocannabinoid-medi-
to enhance the amplitude of eIPSCs in the postseizure ated retrograde regulation of GABA release can also
neurons but not in control cells. A proportion of the CB1 undergo long-term modification in the central nervous
receptors has been suggested to exist in a constitutively system. To our knowledge, the persistent potentiation
active state (i.e., active without a ligand) that depresses of DSI following febrile seizures constitutes the first
transmitter release, and the CB1 receptor antagonist SR demonstration of robust modifications in cannabinoid
has been proposed to act as an inverse agonist at these receptor function in a clinically relevant brain disorder.
receptors to reverse the constitutive activity (Bouaboula Although the question of whether normal patterns of
et al., 1997; Pan et al., 1998; Vasquez and Lewis, 1999). neuronal firing are sufficient to evoke substantial DSI is
In the hippocampi of control animals, SR causes no currently debated (Hampson et al., 2003), intense epilep-
significant enhancement of GABA release (Hoffman and tiform burst firing has been shown to trigger DSI, in
Lupica, 2000; Wilson and Nicoll, 2001). However, an the form of decreased IPSPs following each seizure-like
increase in the number of CB1 receptors after the sei- event (Beau and Alger, 1998). The precise roles of the
zures is expected to also enhance the number of consti- various endocannabinoids in the modulation of seizure
tutively active CB1 receptors (Vasquez and Lewis, 1999), thresholds are likely to be complex (Ameri et al., 1999;
which should result in a greater effect of SR on eIPSCs, Wallace et al., 2002; Clement et al., 2003), since both
as observed in HT animals. Therefore, the sensitivity of GABAergic and glutamatergic terminals on both princi-
the eIPSCs to the CB1 antagonist after the seizures pal cells and interneurons can contain CB-type recep-
is consistent with enhanced expression levels for CB1 tors, some with unusual pharmacological profiles (Ha´jos
receptors. The elevation of the number of CB1 receptors and Freund, 2002). However, the high specificity of the
per perisomatic basket cell synaptic terminal was also seizure-induced alterations in CB1 receptor-mediated
indicated by the fact that the increase in the CB1 recep- signaling described here indicates that the endocanna-
tor expression (shown by the Western blots) took place binoid system may provide novel targets for therapeutic
without an increase in the density of CB-positive syn- drug development (Piomelli et al., 2000; Kathuria et al.,
apses and axonal profiles in the pyramidal cell layer 2003) to control seizures in epilepsy.
following the seizures.
In addition to the enhanced peak DSI and the in-
Experimental Procedures
creased sensitivity of IPSCs to the CB1 antagonist, the
third type of seizure-induced alteration in the canna- Hyperthermia-Induced Seizures
binoid signaling system was the dramatic prolongation The hyperthermia-induced seizure paradigm has been described
elsewhere (Chen et al., 1999, 2001). In brief, on postnatal day 10,of DSI decay. The slower DSI decay was not caused
the core temperature of pups was raised using a regulated streamby a decrease in an AM-404-blockable uptake system,
of moderately heated air. Rectal temperatures were measured atsince AM-404 did not change the decay time constant of
baseline, at 2 min intervals, and at the onset of hyperthermic sei-DSI in either control (consistent with Wilson and Nicoll,
zures, which occur in virtually all rats. Hyperthermia (defined as core
2001) or HT animals. The prolongation of DSI was also temperature 39.5C) was maintained for 30 min, aiming for a core
not due to significant alterations in the endocannabi- temperature of 41C–42C, and the presence and duration of sei-
noid-inactivating enzymatic systems, since the activity zures for each pup were noted at 2 min intervals. Seizure duration
in this model has been shown to average 22 min, and thresholdlevels of either FAAH (Egertova´ et al., 1998) or MGL
temperature to seizure onset averaged 41.1C. Following the hyper-(Dinh et al., 2002) did not change. On the other hand,
thermia period, rats were placed on a cool surface, monitored foralterations in the expression levels of proteins related
15 min, and then returned to home cages.to G protein signaling can modulate the time course of
G protein signals (Chen and Lambert, 2000); therefore,
Slice Preparation
it is possible that the prolongation of DSI decay is also Control and experimental littermate Sprague-Dawley rats (Zivic-
related to the augmented levels of CB1 receptor expres- Miller, Zelienople, PA) were anesthetized with halothane 1–11 weeks
sion after the seizures. after seizure induction, decapitated, and their brains removed. Brain
slices were prepared (Chen et al., 1999) in artificial cerebrospinalThe increase in CB1 receptors occurred selectively
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fluid (ACSF) composed of 126 mM NaCl, 2.5 mM KCl, 26 mM ded in Durcupane. All axonal density calculations were corrected
for shrinkage. For electron microscopic analysis of the density ofNaHCO3, 2 mM CaCl2, 2 mM MgCl2, 1.25 mM NaH2PO4, and 10 mM
glucose. CB1 synapses, the dissector method (see legend to Figures 6D
and 6E) was used, because it is not sensitive to potential changes
in the size of the examined objects (West, 1999). The number ofElectrophysiology
transected CB1 axonal profiles per unit area was also measured inBlind whole-cell recordings were obtained in an interface-type
the electron microscope, and it was also independently determinedchamber at 35C, using an Axopatch-200A amplifier (Axon Instru-
from the preembedding immunogold material at the light micro-ments, Foster City, CA). Spontaneous IPSCs were recorded in ACSF
scopic level (due to the large size of the colloidal gold particle, thecontaining 10 M D-2-amino-5-phosphovaleric acid (APV; Tocris),
staining was confined to the surface of the sections, providing an5 M 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris), and un-
essentially 2D staining pattern ideal for quantitative sampling). Fromless specifically indicated, 5 M carbachol (Sigma). For miniature
the immunogold material, 24 samples (200 m 	 300 m areas) perIPSCs, the ACSF contained 10 M APV, 5 M CNQX, and 1 M
each animal were digitally photographed and background sub-tetrodotoxin (TTX; Calbiochem). To evoke perisomatic IPSCs
tracted using a high-pass filter (NIHImage). In the resulting binary(latency 
3.1 ms), constant-current stimuli (20 s) were applied
images, the CB1 axonal profiles (Figures 6F and 6G) were countedthrough a bipolar 90 m tungsten electrode. The placement and
(note that only the number, not the size or staining intensity, of thedistance of the recording and stimulating electrodes were kept con-
CB1 profiles could be determined with this technique).stant as described (Chen et al., 1999). For minimal stimulation, a
patch pipette was used as a stimulating electrode. Pipette solutions
for DSI experiments consisted of 140 mM CsCl, 2 mM MgCl2, 10 High-Performance Liquid Chromatography/Mass Spectrometry
The HPLC/MS experiments were conducted as described previouslymM N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES),
3 mM QX-314, 0.2 mM EGTA, 1 mM ATP, and 0.2 mM GTP (for (Dinh et al., 2002; Giuffrida et al., 2000). In brief, hippocampi from
control and postseizure rats were immediately frozen and homoge-eIPSCs, no EGTA, ATP, or GTP was included in the pipette; for DSE,
CsCl was replaced with K-gluconate). The depolarizing pulse used nized in methanol. Lipids were extracted with chloroform:methanol
(2:1, v/v). Samples were centrifuged (3000 rpm) for 5 min, and theto evoke DSI was a 100 ms to 5 s step to 0 mV from holding potential
(usually 60 mV); for DSE, the step was 10 s. For DSE, picrotoxin organic phase was recovered and evaporated under a stream of N2
gas. Lipids were resuspended in 1 ml of chloroform and purifiedwas included in the ACSF. Atropine was obtained from Research
Biomedical International (RBI); LY341495, WIN55212-2, and AM404 over silica columns. Samples were loaded onto silica columns,
washed with 1 ml chloroform, and eluted with 2 ml of a mixture ofwere from Tocris. SR141716A was obtained from SRI International
(Palo Alto, CA) through the National Institute of Mental Health’s chloroform:methanol (9:1, v/v). Samples were then evaporated un-
der N2 gas and resuspended in 100 l of a mixture of chloro-Chemical Synthesis and Drug Supply Program; -agatoxin TK was
from Sigma. form:methanol (2:3, v/v). HPLC/MS analyses were conducted as
described (Dinh et al., 2002). 2H4-labeled fatty ethanolamides were
synthesized in the laboratory, and 2-[2H8]AG was purchased fromAnalysis
Cayman Chemical (Ann Arbor, MI).Recordings were filtered at 3 kHz before digitization at 20 kHz using
Strathclyde Electrophysiology Software (courtesy of Dr. J. Demp-
ster, University of Strathclyde) and Synapse software (courtesy of Enzyme Activity Assays
MGL and FAAH assays were performed as described (Dinh et al.,Dr. Y. De Koninck, McGill University). Statistical analyses (most often
a t test) were performed with SigmaPlot or SPSS, with a level of 2002; Kathuria et al., 2003). In brief, 50 g of protein from hippocam-
pal homogenates was incubated in 50 mM tris buffer (pH 7.4) con-significance of p 
 0.05. Data are presented as mean  SEM, and
“n” is the number of recorded cells (or, in some experiments, the taining 0.5 mg/ml BSA in final volume of 0.5 ml for 30 min at 37C
with arachidonoyl-[3H]ethanolamide (10 M; 10,000 cpm) (for FAAH)number of animals).
or with 2-oleoyl-[3H]glycerol (10 M; 50,000 cpm) (both from Ameri-
can Radiolabeled Chemicals) (for MGL). The reaction was stopped,Double-Label Immunocytochemistry
and products were separated by organic solvent extraction (chloro-Double-label immunostaining was performed as described pre-
form:methanol, 1:1); the aqueous phase was taken for radioactiveviously (Katona et al., 2000). In brief, control and HT littermate pairs
measurements by scintillation counting.were perfused 6 or 7 days post-HT with 4% paraformaldehyde, 0.2%
picric acid, and 0.1% glutaraldehyde. Sections were cut at 50 m,
cryoprotected in 30% sucrose/10% glycerol solution, and freeze Western Blots
Hippocampi were rapidly dissected out and homogenized in 5-foldthawed over liquid nitrogen. Sections were washed, blocked in 2.5%
bovine serum albumin solution, and incubated for 48 hr at 4C in (volume/weight) excess buffer containing 25 mM HEPES, 10 mM
EDTA, 6 mM MgCl, 100M PMSF, 10M leupeptin, 100M benzam-rabbit anti-CB1 (1:1500; raised against the C terminus; Ha´jos et al.,
2000) in combination with either mouse anti-cholecystokinin (CCK) idine, 10 M aprotenin (pH 7.4). Homogenates were centrifuged for
5 min at 1000 	 g, the supernatants were saved, and the pelletsantibody (1:3000; Antibody 9303 kindly provided by CURE/Digestive
Diseases Research Center/RIA Core, NIH grant #DK41301) or mouse were rehomogenized in buffer and centrifuged as above. The protein
concentrations of the combined supernatants were determined us-anti-parvalbumin (PV) antibody (1:2000; Antibody P-3171 Sigma,
Saint Louis, MO). The laboratory or company of origin previously ing Bio-Rad protein assay. Proteins (40 g) from each animal were
separated by SDS-PAGE and transferred to nitrocellulose. Westernconfirmed the specificity of each antibody. The sections were
washed, incubated for 1 hr in a combination of donkey Cy-3-conju- blot analysis was performed blind with respect to animal treatment
using an antibody raised against the last 14 amino acids of rat CB1gated anti-rabbit IgG (1:200) and goat FITC-conjugated anti-mouse
IgG (1:200; both from Jackson ImmunoResearch, West Grove, PA), fused to glutathione S-transferase (CB1 L14; 1:250). The antibody
was purified and specificity verified as described in Katona et al.washed again, and mounted using Vectashield (Vector Laboratories,
Burlingame, CA). Each antibody was also used individually on con- (2000). Specific binding was blocked by preincubation of CB1 anti-
serum with excess fusion protein used for immunization. To ensuretrol sections to verify that there was no bleed-through immunoreac-
tivity. equal loading of proteins, the upper portion of the blot containing
the higher molecular weight proteins was probed with antibodies
(Sigma) to neurofilament polypeptides with apparent molecularElectron Microscopy and Preembedding Immunogold Techniques
weight of 68 kDa, 160 kDa, and 200 kDa, respectively. RadioactivityFifty micrometer sections were incubated with the antibody against
was quantified using a PhosphorImager (Molecular Dynamics).the CB1 receptor (see above; 1:1000 for immunogold; 1:6000 for
3,3-diaminobenzidine [DAB]) for 48 hr, followed by biotinylated
goat-anti-rabbit (1:200) and Elite ABC (1:200). For immunogold stain- Acknowledgments
ing, tyramid intensification was performed (1:40, 10 min), followed
by incubation in a streptavidin-labeled 0.8 nm gold colloidal solution We thank R. Zhu and S. Kathuria for technical assistance; and Drs.
N. Lambert and D. Lewis for discussions. This work was supportedovernight. The sections were osmicated, dehydrated, and embed-
Neuron
610
by NIH grant NS38580 (to I.S.) and by grants NS33213 (to M.S.), fies roles for both cloned and novel mGlu receptors in hippocampal
synaptic plasticity. Neuropharmacology 37, 1445–1458.DA12447, and DA3412 (to D.P.) and DA11322 and DA00286 (to K.M.).
Giuffrida, A., Rodriguez de Fonseca, F., and Piomelli, D. (2000).
Quantification of bioactive acylethanolamides in rat plasma by elec-Received: February 19, 2003
Revised: June 23, 2003 trospray mass spectrometry. Anal. Biochem. 280, 87–93.
Accepted: July 17, 2003 Ha´jos, N., and Freund, T.F. (2002). Pharmacological separation of
Published: August 13, 2003 cannabinoid sensitive receptors on hippocampal excitatory and in-
hibitory fibers. Neuropharmacology 43, 503–510.
References Ha´jos, N., Katona, I., Naiem, S.S., MacKie, K., Ledent, C., Mody, I.,
and Freund, T.F. (2000). Cannabinoids inhibit hippocampal GABAer-
Ameri, A., Wilhelm, A., and Simmet, T. (1999). Effects of the endo- gic transmission and network oscillations. Eur. J. Neurosci. 12,
genous cannabinoid, anandamide, on neuronal activity in rat hippo- 3239–3249.
campal slices. Br. J. Pharmacol. 126, 1831–1839. Hampson, R.E., Zhuang, S.-Y., Weiner, J.L., and Deadwyler, S.A.
Beau, F.E., and Alger, B.E. (1998). Transient suppression of GABAA- (2003). Functional significance of cannabinoid-mediated, depolar-
receptor-mediated IPSPs after epileptiform burst discharges in CA1 ization-induced suppression of inhibition (DSI) in the hippocampus.
pyramidal cells. J. Neurophysiol. 79, 659–669. J. Neurophysiol. 90, 55–65.
Beltramo, M., Stella, N., Calignano, A., Lin, S.Y., Makriyannis, A., Hoffman, A.F., and Lupica, C.R. (2000). Mechanisms of cannabinoid
and Piomelli, D. (1997). Functional role of high-affinity anandamide inhibition of GABA(A) synaptic transmission in the hippocampus. J.
transport, as revealed by selective inhibition. Science 277, 1094– Neurosci. 20, 2470–2479.
1097. Freund, T.F., and Buzsa´ki, G. (1996). Interneurons of the hippocam-
Bouaboula, M., Perrachon, S., Milligan, L., Canat, X., Rinaldi-Car- pus. Hippocampus 6, 347–470.
mona, M., Portier, M., Barth, F., Calandra, B., Pecceu, F., Lupker, Holmes, G.L., and Ben-Ari, Y. (1998). Seizures in the developing
J., et al. (1997). A selective inverse agonist for central cannabinoid brain: Perhaps not so benign after all. Neuron 21, 1231–1234.
receptor inhibits mitogen-activated protein kinase activation stimu-
Kathuria, S., Gaetani, S., Fegley, D., Valino, F., Duranti, A., Tontini,
lated by insulin or insulin-like growth factor 1. Evidence for a new
A., Mor, M., Tarzia, G., Rana, G.L., Calignano, A., et al. (2003). Modu-
model of receptor/ligand interactions. J. Biol. Chem. 272, 22330–
lation of anxiety through blockade of anandamide hydrolysis. Nat.
22339.
Med. 9, 76–81.
Brooks-Kayal, A.R., Shumate, M.D., Jin, H., Rikhter, T.Y., and
Katona, I., Sperlagh, B., Sik, A., Kafalvi, A., Vizi, E.S., Mackie, K.,
Coulter, D.A. (1998). Selective changes in single cell GABAA receptor and Freund, T.F. (1999). Presynaptically located CB1 cannabinoid
subunit expression and function in temporal lobe epilepsy. Nat.
receptors regulate GABA release from axon terminals of specific
Med. 4, 1166–1172.
hippocampal interneurons. J. Neurosci. 19, 4544–4558.
Chen, H., and Lambert, N.A. (2000). Endogenous regulators of G Katona, I., Sperlagh, B., Magloczky, Z., Santha, E., Kofalvi, A., Czir-
protein signaling proteins regulate presynaptic inhibition at rat hip- jak, S., Mackie, K., Vizi, E.S., and Freund, T.F. (2000). GABAergic
pocampal synapses. Proc. Natl. Acad. Sci. USA 97, 12810–12815. interneurons are the targets of cannabinoid actions in the human
Chen, K., Baram, T.Z., and Soltesz, I. (1999). Febrile seizures in hippocampus. Neuroscience 100, 797–804.
the developing brain result in persistent modification of neuronal Kim, J., Isokawa, M., Ledent, C., and Alger, B.E. (2002). Activation
excitability in limbic circuits. Nat. Med. 5, 888–894. of muscarinic acetylcholine receptors enhances the release of en-
Chen, K., Aradi, I., Thon, N., Eghbal-Ahmadi, M., Baram, T.Z., and dogenous cannabinoids in the hippocampus. J. Neurosci. 22,
Soltesz, I. (2001). Persistently modified h-channels after complex 10182–10191.
febrile seizures convert the seizure-induced enhancement of inhibi- Kreitzer, A.C., and Regehr, W.G. (2001). Retrograde inhibition of
tion to hyperexcitability. Nat. Med. 7, 331–336. presynaptic calcium influx by endogenous cannabinoids at excit-
Chevaleyre, V., and Castillo, P.E. (2003). Heterosynaptic LTD of hip- atory synapses onto Purkinje cells. Neuron 29, 717–727.
pocampal GABAergic synapses: a novel role of endocannabinoids McBain, C.J., and Fisahn, A. (2001). Interneurons unbound. Nat.
in regulating excitability. Neuron 38, 461–472. Rev. Neurosci. 2, 11–23.
Clement, A.B., Hawkins, E.G., Lichtman, A.H., and Cravatt, B.F. Nusser, Z., Ha´jos, N., Somogyi, P., and Mody, I. (1998). Increased
(2003). Increased seizure susceptibility and proconvulsant activity number of synaptic GABA(A) receptors underlies potentiation at
of anandamide in mice lacking fatty acid amide hydrolase. J. Neu- hippocampal inhibitory synapses. Nature 395, 172–177.
rosci. 23, 3916–3923.
Ohno-Shosaku, T., Maejima, T., and Kano, M. (2001). Endogenous
Cravatt, B.F., Giang, D.K., Mayfield, S.P., Boger, D.L., Lerner, R.A., cannabinoids mediate retrograde signals from depolarized postsyn-
and Gilula, N.B. (1996). Molecular characterization of an enzyme that aptic neurons to presynaptic terminals. Neuron 29, 729–738.
degrades neuromodulatory fatty-acid amides. Nature 384, 83–87. Ohno-Shosaku, T., Tsubokawa, H., Mizushima, I., Yoneda, N., Zim-
Desarnaud, F., Cadas, H., and Piomelli, D. (1995). Anandamide ami- mer, A., and Kano, M. (2002). Presynaptic cannabinoid sensitivity is
dohydrolase activity in rat brain microsomes. Identification and par- a major determinant of depolarization-induced retrograde suppres-
tial characterization. J. Biol. Chem. 270, 6030–6035. sion at hippocampal synapses. J. Neurosci. 22, 3864–3872.
Di Marzo, V., Fontana, A., Cadas, H., Schinelli, S., Cimino, G., Pan, X., Ikeda, S.R., and Lewis, D.L. (1998). SR 141716A acts as
Schwartz, J.C., and Piomelli, D. (1994). Formation and inactivation an inverse agonist to increase neuronal voltage-dependent Ca2
of endogenous cannabinoid anandamide in central neurons. Nature currents by reversal of tonic CB1 cannabinoid receptor activity. Mol.
372, 686–691. Pharmacol. 54, 1064–1072.
Dinh, T.P., Carpenter, D., Leslie, F.M., Freund, T.F., Katona, I., Sensi, Piomelli, D., Giuffrida, A., Calignano, A., and Rodriguez de Fonseca,
S.L., Kathuria, S., and Piomelli, D. (2002). Brain monoglyceride lipase F. (2000). The endocannabinoid system as a target for therapeutic
participating in endocannabinoid inactivation. Proc. Natl. Acad. Sci. drugs. Trends Pharmacol. Sci. 21, 218–224.
USA 99, 10819–10824. Pitler, T.A., and Alger, B.E. (1992). Postsynaptic spike firing reduces
Egertova´, M., Giang, D.K., Cravatt, B.F., and Elphick, M.R. (1998). synaptic GABAA responses in hippocampal pyramidal cells. J. Neu-
A new perspective on cannabinoid signalling: complementary local- rosci. 12, 4122–4132.
ization of fatty acid amide hydrolase and the CB1 receptor in rat Rinaldi-Carmona, M., Barth, F., Heaulme, M., Shire, D., Calandra,
brain. Proc. R. Soc. Lond. B. Biol. Sci. 265, 2081–2085. B., Congy, C., Martinez, S., Maruani, J., Neliat, G., Caput, D., Ferrara,
P., Soubrie, P., Breliere, J.C., and Le Fur, G. (1994). SR141716A, aFitzjohn, S.M., Bortolotto, Z.A., Palmer, M.J., Doherty, A.J., Ornstein,
P.L., Schoepp, D.D., Kingston, A.E., Lodge, D., and Collingridge, potent and selective antagonist of the brain cannabinoid receptor.
FEBS Lett. 350, 240–244.G.L. (1998). The potent mGlu receptor antagonist LY341495 identi-
Long-Term Plasticity of Cannabinoid Signaling
611
Shinnar, S. (1998). Prolonged febrile seizures and mesial temporal
sclerosis. Ann. Neurol. 43, 411–412.
Stella, N., Schweitzer, P., and Piomelli, D. (1997). A second endoge-
nous cannabinoid that modulates long-term potentiation. Nature
388, 773–778.
Toth, Z., Xiao-Xin, Y., Haftoglou, S., Ribak, C.E., and Baram, T.Z.
(1998). Seizure-induced neuronal injury: vulnerability to febrile sei-
zures in an immature rat model. J. Neurosci. 18, 4285–4294.
Tsou, K., Mackie, K., Sanudo-Pena, M.C., and Walker, J.M. (1999).
Cannabinoid CB1 receptors are localized primarily on cholecystoki-
nin-containing GABAergic interneurons in the rat hippocampal for-
mation. Neuroscience 93, 969–975.
Varma, N., Carlson, G.C., Ledent, C., and Alger, B.E. (2001). Metabo-
tropic glutamate receptors drive the endocannabinoid system in
hippocampus. J. Neurosci. 21, RC188.
Varma, N., Brager, D., Morishita, W., Lenz, R.A., London, B., and
Alger, B. (2002). Presynaptic factors in the regulation of DSI expres-
sion in hippocampus. Neuropharmacology 43, 550–562.
Vasquez, C., and Lewis, D.L. (1999). The CB1 cannabinoid receptor
can sequester G-proteins, making them unavailable to couple to
other receptors. J. Neurosci. 19, 9271–9280.
Walker, M.C., and Kullmann, D.M. (1999). Febrile convulsions: a
‘benign’ condition? Nat. Med. 5, 871–872.
Wallace, M.J., Martin, B.R., and DeLorenzo, R.J. (2002). Evidence
for a physiological role of endocannabinoids in the modulation of
seizure threshold and severity. Eur. J. Pharmacol. 452, 295–301.
West, M.J. (1999). Stereological methods for estimating the total
number of neurons and synapses: issues of precision and bias.
Trends Neurosci. 22, 51–61.
Wilson, R.I., and Nicoll, R.A. (2001). Endogenous cannabinoids me-
diate retrograde signalling at hippocampal synapses. Nature 410,
588–592.
Wilson, R.I., Kunos, G., and Nicoll, R.A. (2001). Presynaptic specific-
ity of endocannabinoid signaling in the hippocampus. Neuron 31,
453–462.
